Jump Financial, LLC Alaunos Therapeutics, Inc. Transaction History

Jump Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$1.44 - $2.73 $24,912 - $47,229	-17,300 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$2.63 - $3.67 $45,499 - $63,491	17,300 New	17,300 $46,000
Q4 2020 Feb 12, 2021	SELL	$2.09 - $3.09 $127,907 - $189,108	-61,200 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$2.39 - $3.43 $146,268 - $209,916	61,200 New	61,200 $154,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $607M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.